Use access key #2 to skip to page content.

portefeuille (99.51)

fund strategy

Recs

10

April 08, 2010 – Comments (121)

My virtual fund is a spinoff fund taking some of the intellectual property (me) and my trades from the parent fund, the tigerpack fund project (see here).

I made my first trade on March 8, 2010 and my 207th trade was "executed" a few minutes ago (see here). I am currently around 6.5% in the green (having subtracted reasonable "commission and fees"). I think I am reasonably "diversified" and I guess I am following some kind of "event driven / value investing" strategy.

121 Comments – Post Your Own

#1) On April 08, 2010 at 3:43 PM, portefeuille (99.51) wrote:

fund positions.



Report this comment
#2) On April 08, 2010 at 3:58 PM, portefeuille (99.51) wrote:

sell 4300 RXII, limit 4.68 USD.

Report this comment
#3) On April 08, 2010 at 4:38 PM, portefeuille (99.51) wrote:

sold 4300 RXII 4.73 USD.

 

performance: +6.89%.

cash: -$114402.71.

 

performance of some indices for the period starting at the open of 03/08/10 and ending at the close of 04/08/10.

S&P 500 index: +4.22%,
NASDAQ index: +4.75%,
NASDAQ biotech index: +3.51%.

Report this comment
#4) On April 08, 2010 at 7:10 PM, portefeuille (99.51) wrote:

buy 1400 AEI:GR in Xetra trading, limit 9.80 EUR.

 

Allgeier Holding in Xetra trading.



enlarge

Report this comment
#5) On April 08, 2010 at 7:15 PM, Momentum21 (93.65) wrote:

Keep up the good work...and thanks for sharing. I aspire to a similar "style" but don't have the same passion for Biotech due to my lack of understanding...the IBB is for me. : )

Report this comment
#6) On April 08, 2010 at 7:39 PM, portefeuille (99.51) wrote:

a comment on "order execution" (also see comments #25 here and #53 here).

When I try to determine whether an "intelligent trader" would have been able to get a certain order executed (or partially "filled") and what the average price per share for the executed order would have been I look at the "order book" (if I have access. usually I can see at least part of it via brokerages) and the actual trades. I then throw in some "experience" to determine a "reasonable" price. The "intelligencent" trader I am assuming is simply supposed to enter the order in a way that it does not affect the "price movement" of the stock by too much. So it is rather a "clever" trader, not necessarily one with a high IQ, hehe ...

Report this comment
#7) On April 08, 2010 at 7:49 PM, portefeuille (99.51) wrote:

#5 Well, I guess I really have some passion for biopharmaceuticals. I think it is the real fun sector if you want to do some "stock research".

Report this comment
#8) On April 08, 2010 at 8:03 PM, portefeuille (99.51) wrote:

I should also try to state at least some kind of target. I think I will leave this "fund" a pure equity fund (If I get too bored with that I can just add a new fund). And I will try to keep cash above -5% of "total assets". I am just not sure sure whether I simply want to beat some benchmark or beat a bunch of benchmarks including the "zero benchmark (i.e. 'cash')". I guess it's my party and I do what I want to. I just don't know what I want! Maybe I will do it the Leuthold way and create a sister fund, the Portefeuille Short Fund. I think I will keep cash at below +5% of assets and if I should ever become really "bearish" I will tell everyone not to "buy" my fund. That would also be the Leuthold way ...

Report this comment
#9) On April 08, 2010 at 11:41 PM, Momentum21 (93.65) wrote:

...so are you investing in a Leuthold-like "select industries strategy" (Biotech in this case) without the sector rotation?

you could mirror your performance to a Morningstar Equity Index for hedge funds...Global Equity HF USD (6% return in the month of March). 

Report this comment
#10) On April 09, 2010 at 8:05 AM, portefeuille (99.51) wrote:

Good idea, I take that as a benchmark. I think I will do some sector rotation as well.

Report this comment
#11) On April 09, 2010 at 8:55 AM, portefeuille (99.51) wrote:

bought 1200 ORX:SS 5.96 USD (43.00 SEK / 7.21 SEK/USD),
bought 1400 AEI:GR 11.94 USD (8.91 EUR * 1.34 EUR/USD).

Report this comment
#12) On April 09, 2010 at 9:01 AM, portefeuille (99.51) wrote:

-------------

Reliance to invest $1.7 bln for Marcellus JV-sources

...

MUMBAI, April 9 (Reuters) - Indian energy major Reliance Industries (RELI.BO) plans to invest $1.7 billion for a joint venture with Atlas Energy (ATLS.O) to develop the U.S. firm's Marcellus Shale gas operations, two sources with direct knowledge of the matter said.

India's largest listed firm with interests including oil and gas exploration, refining, petrochemicals and retail may pick up 40 percent in the joint venture, said the sources, who declined to be named as they were not authorised to speak with the media.

The companies have been holding talks for a deal, and Reliance could make a formal proposal to Atlas soon, the sources said.

...

-------------

Report this comment
#13) On April 09, 2010 at 9:05 AM, portefeuille (99.51) wrote:

sell 170 ATLS, limit 38.70 USD, in extended or regular trading.

Report this comment
#14) On April 09, 2010 at 9:11 AM, portefeuille (99.51) wrote:

Adding Leverage to an Already Volatile Sector: ProShares Launches 2x Long, Short Biotech ETFs

The Long Term Behaviour of Leveraged ETFs

 

Report this comment
#15) On April 09, 2010 at 9:18 AM, portefeuille (99.51) wrote:

buy 450 CML, limit 12.70 USD.

 

April 7, 2010 Compellent Provides Preliminary Financial Results for First Quarter 2010

April 8, 2010 Canaccord Turns Cautious On Data Storage; Downgrades 5 Stks

 

Report this comment
#16) On April 09, 2010 at 9:27 AM, portefeuille (99.51) wrote:

sell 300 PALM, limit 5.90 USD, in extended or regular trading.

Report this comment
#17) On April 09, 2010 at 9:42 AM, portefeuille (99.51) wrote:

sell 1800 RXII, limit $5.07.

Report this comment
#18) On April 09, 2010 at 9:56 AM, portefeuille (99.51) wrote:

bought 450 CML 12.70 USD,
sold 1800 RXII 5.10 USD.

 

performance: +7.6%,
cash: -$134909.60.

 

Report this comment
#19) On April 09, 2010 at 10:25 AM, portefeuille (99.51) wrote:

S&P 500 index in EUR (see this post).



enlarge

 

currently at around 1190.43 / 1.3458 ≈ 884.55. 

Report this comment
#20) On April 09, 2010 at 10:46 AM, portefeuille (99.51) wrote:

sell 4500 ECX:GR in Xetra or Frankfurt trading, limit 2.82 EUR.

Report this comment
#21) On April 09, 2010 at 10:51 AM, portefeuille (99.51) wrote:

Epigenomics Raises $44.2M in Financing

 

Epigenomics in Xetra trading.



enlarge

Report this comment
#22) On April 09, 2010 at 10:56 AM, portefeuille (99.51) wrote:

sold 4500 ECX:GR 3.81 USD (2.83 EUR * 1.3453 USD/EUR).

Report this comment
#23) On April 09, 2010 at 11:12 AM, portefeuille (99.51) wrote:

sell 140 SA, limit 28.90 USD.

Report this comment
#24) On April 09, 2010 at 11:34 AM, portefeuille (99.51) wrote:

sold 140 SA 28.90 USD.

 

sell 2200 BIOD, limit 4.86 USD.

Report this comment
#25) On April 09, 2010 at 11:44 AM, portefeuille (99.51) wrote:

sold 2200 BIOD limit 4.86 USD.

 



enlarge

 

performance: +7.74%.

Report this comment
#26) On April 09, 2010 at 12:02 PM, portefeuille (99.51) wrote:

sell 12000 XOMA, limit 0.628 USD.

Report this comment
#27) On April 09, 2010 at 2:14 PM, portefeuille (99.51) wrote:

sold 12000 XOMA 0.6299 USD,
bought 130 CHL 51.15 USD (ask).

Report this comment
#28) On April 09, 2010 at 2:20 PM, portefeuille (99.51) wrote:

sold 140 RHT 30.67 USD (bid).

Report this comment
#29) On April 09, 2010 at 2:51 PM, portefeuille (99.51) wrote:

sell 1150 ATPG, limit 19.32 USD.

Report this comment
#30) On April 09, 2010 at 3:47 PM, portefeuille (99.51) wrote:

sold 1150 ATPG 19.32 USD,
sold 1300 BRCD 6.41 USD (bid).

Report this comment
#31) On April 09, 2010 at 3:53 PM, portefeuille (99.51) wrote:

sell 900 DRWI, limit 10.40 USD.

Report this comment
#32) On April 09, 2010 at 4:35 PM, portefeuille (99.51) wrote:

update.

performance: +7.95%,
cash: -$67445.11.

performance of some indices for the period starting at the open of 03/08/10 and ending at the close of 04/09/10.

S&P 500 index: +4.92%,
NASDAQ index: +5.49%,
NASDAQ biotech index: +3.59%.

 

Report this comment
#33) On April 09, 2010 at 4:36 PM, portefeuille (99.51) wrote:

yeay!!!!!!!!!!

Report this comment
#34) On April 10, 2010 at 4:55 AM, portefeuille (99.51) wrote:

buy 260 VOW:GR in Xetra or Frankfurt trading, limit 73.00 EUR,
buy 140 PAH3:GR in Xetra or Frankfurt trading, limit 46.50 EUR.

Report this comment
#35) On April 11, 2010 at 1:27 AM, portefeuille (99.51) wrote:

buy 1500 RXII, limit 4.75 USD in extended or regular trading.

Report this comment
#36) On April 12, 2010 at 3:33 AM, portefeuille (99.51) wrote:

sell 300 ETE:GA (1500 NBG), limit 15.10 EUR.

Report this comment
#37) On April 12, 2010 at 4:47 AM, portefeuille (99.51) wrote:

bought 260 VOW:GR 96.99 USD (71.12 EUR  * 1.3638 USD/EUR),
bought 140 PAH3:GR 61.64 USD (45.20 EUR  * 1.3638 USD/EUR),
sold 1500 NBG 4.142 USD (15.20 EUR * 1.3625 USD/EUR / 5).

performance: +7.98%,
cash: -$95140.53.

Report this comment
#38) On April 12, 2010 at 4:56 AM, portefeuille (99.51) wrote:

buy 20000 SLN:LN, limit 9.2 p.

Report this comment
#39) On April 12, 2010 at 8:54 AM, portefeuille (99.51) wrote:

bought 20000 SLN:LN 0.1419 USD (0.092 GBP * 1.542 USD/GBP).

Report this comment
#40) On April 12, 2010 at 9:35 AM, portefeuille (99.51) wrote:

sell 340 ATPG, limit 19.55 USD.

Report this comment
#41) On April 12, 2010 at 9:44 AM, portefeuille (99.51) wrote:

sold 340 ATPG 19.56 USD,
sold 300 PALM 5.90 USD.

Report this comment
#42) On April 12, 2010 at 9:58 AM, portefeuille (99.51) wrote:

sold 170 ATLS 38.70 USD.

+8.58%.

Report this comment
#43) On April 12, 2010 at 10:06 AM, portefeuille (99.51) wrote:

sell 470 ATPG, limit 20.15 USD.

Report this comment
#44) On April 12, 2010 at 10:28 AM, portefeuille (99.51) wrote:

sell 6500 HLCS, limit 0.97 USD.

Report this comment
#45) On April 12, 2010 at 10:37 AM, portefeuille (99.51) wrote:

sold 470 ATPG 20.15 USD,
sold 6500 HLCS 0.97 USD.

performance: +8.73%,
cash: -$67322.91. 

Report this comment
#46) On April 12, 2010 at 10:39 AM, portefeuille (99.51) wrote:

sold 5000 XOMA 0.6599 (bid).

Report this comment
#47) On April 12, 2010 at 10:49 AM, portefeuille (99.51) wrote:

sell 900 MYRX 5.01 USD (bid).

Report this comment
#48) On April 12, 2010 at 11:06 AM, portefeuille (99.51) wrote:

sold 900 MYRX 5.01 USD,
bought 1200 EPI 24.02 USD (ask).

Report this comment
#49) On April 12, 2010 at 11:32 AM, portefeuille (99.51) wrote:

bought 1500 RXII 4.75 USD.

Report this comment
#50) On April 12, 2010 at 11:53 AM, portefeuille (99.51) wrote:

fund positions.

(1200 shares of ORX:SS are left out as yahoo finance does not do the currency conversion correctly.)



 

performance: +8.95%,
cash: -$95543.41.

Report this comment
#51) On April 12, 2010 at 12:57 PM, portefeuille (99.51) wrote:

sell 160 RDEA, limit 23.95 USD.

Report this comment
#52) On April 12, 2010 at 1:12 PM, portefeuille (99.51) wrote:

sell 1900, limit 1.45 USD.

Report this comment
#53) On April 12, 2010 at 1:13 PM, portefeuille (99.51) wrote:

sell 1900, limit 1.45 USD.

sell 1900 MRNA, limit 1.45 USD.

Report this comment
#54) On April 12, 2010 at 3:49 PM, portefeuille (99.51) wrote:

sold 3400 YMI 1.52 USD (bid).

Report this comment
#55) On April 12, 2010 at 4:24 PM, portefeuille (99.51) wrote:

sold 160 RDEA 23.95 USD.

performance: +8.90%
cash: -86583.41.

Report this comment
#56) On April 13, 2010 at 9:13 AM, portefeuille (99.51) wrote:

sell 4000 XOMA, limit 0.92 USD, in regular trading.or today's pre-market trading.

Report this comment
#57) On April 13, 2010 at 9:33 AM, portefeuille (99.51) wrote:

buy to cover 350 HUSA, limit 12.10 USD.

Report this comment
#58) On April 13, 2010 at 10:17 AM, portefeuille (99.51) wrote:

sell 3400 ARRY, limit 2.93 USD.

Report this comment
#59) On April 13, 2010 at 10:25 AM, portefeuille (99.51) wrote:

sold 3400 ARRY 2.93 USD.

performance: +9.01%
cash: -76661.41.

Report this comment
#60) On April 13, 2010 at 10:55 AM, portefeuille10 (98.35) wrote:

buy 1100 AVNR, limit 3.12 USD.

Report this comment
#61) On April 13, 2010 at 11:06 AM, portefeuille10 (98.35) wrote:

bought 1100 AVNR 3.11 USD.

 

February 9, 2010 BIO CEO & Investor Conference presentation

 

Report this comment
#62) On April 13, 2010 at 2:55 PM, portefeuille (99.51) wrote:

sell 1230 IMGN, limit 8.83 USD.

Report this comment
#63) On April 13, 2010 at 3:06 PM, portefeuille (99.51) wrote:

sold 1230 IMGN 8.84 USD.

performance: +9.47%.

Report this comment
#64) On April 13, 2010 at 3:09 PM, portefeuille (99.51) wrote:

buy 330 PALM, limit 5.19 USD.

Report this comment
#65) On April 13, 2010 at 3:45 PM, portefeuille (99.51) wrote:

bought 330 PALM 5.18 USD,
bought 430 QQQQ 49.33 USD (ask).

Report this comment
#66) On April 14, 2010 at 2:16 AM, portefeuille (99.51) wrote:

update.

I have made 240 trades so far. Using as before 20 USD per trade and having accumulated "margin & borrowing cost" of 200 USD (guessing. only short position currently are 600 HUAS shares) you get

performance after "commission&fees": +9.88%,
performance before "commission&fees": +10.02%,
cash: -92210.51.

So I guess the first 10% were the easy part, hehe ...

performance of some indices for the period starting at the open of 03/08/10 (I started the fund on that day) and ending at the close of 04/13/10.

S&P 500 index: +4.92%,
NASDAQ index: +5.49%,
NASDAQ biotech index: +3.59%,
Russell 2000 index: +6.17%.

 

the trades.






Report this comment
#67) On April 14, 2010 at 4:25 AM, portefeuille (99.51) wrote:

buy 3600 AB1:GR in Xetra and Frankfurt trading, limit 4.32 EUR.

Report this comment
#68) On April 14, 2010 at 4:33 AM, portefeuille (99.51) wrote:

bought 370 HEI:GR in Xetra trading 44.21 EUR (ask).

Report this comment
#69) On April 14, 2010 at 4:50 AM, portefeuille (99.51) wrote:

bought 370 HEI:GR in Xetra trading 44.21 EUR (ask).

bought 370 HEI:GR in Xetra trading 60.29 USD (44.21 EUR (ask) * 1.3638 USD/EUR).

bought 3600 AB1:GR 5.8827 USD (4.31 EUR * 1.3646 USD/EUR).

performance: +9.85%. 

Report this comment
#70) On April 14, 2010 at 6:39 AM, portefeuille (99.51) wrote:

bought 310 AIXA:GR (AIXG) 26.60 EUR (ask).

Report this comment
#71) On April 14, 2010 at 6:56 AM, portefeuille (99.51) wrote:

bought 310 AIXA:GR (AIXG) 26.60 EUR (ask).

bought 310 AIXA:GR (AIXG) 36.20 USD (26.60 EUR (ask) * 1.361 USD/EUR).

  

comment on ADRs. I will assume that ADRs and the underlying shares can be "interchanged" easily, so I might buy/sell Aixtron shares (AIXA:GR) on Xetra and sell/buy the corresponding ADRs.

Feel free to comment on whether that is a reasonable assumption and what would be realistic "transaction costs"?

If the transaction costs would be too high I would need to keep the "regular shares" and the ADRs separated ...

 

Report this comment
#72) On April 14, 2010 at 8:56 AM, portefeuille (99.51) wrote:

sell 22000 CRXX, limit 1.55 USD, in extended or regular trading.

Report this comment
#73) On April 14, 2010 at 9:05 AM, portefeuille (99.51) wrote:

-------------

CombinatoRx Discovers Novel Multi-Target Mechanism for the Treatment of Hematologic Malignancies

Press Release Source: CombinatoRx, Incorporated On Wednesday April 14, 2010, 7:30 am EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated (NASDAQ: CRXX - News) today announced the publication of new preclinical data in BLOOD, The Journal of the American Society of Hematology. In the article entitled, “Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multi-target mechanism discovered through systematic combination screening in B-cell malignancies,” Rickles, et.al., Blood First Edition Paper, prepublished online April 9, 2010; DOI 10.1182/blood-2009-11-252668, CombinatoRx researchers, in collaboration with the Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, demonstrate the powerful and unexpected synergistic interactions of A2A Agonist and PDE Inhibitors as potential adjunctive therapy to glucocorticoid (GC) containing regimens in the treatment of multiple myeloma (MM) and other B-cell malignancies.

“Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies,” said Paul G. Richardson, MD, Clinical Director, Jerome Lipper Center for Multiple Myeloma at Dana-Farber Cancer Institute and Associate Professor of Medicine, Harvard Medical School.

By deploying the CombinatoRx combination high throughput screening (cHTS) technology to identify compounds that synergize with GCs to inhibit the proliferation of the MM cells, researchers were able to identify two classes of targeted agents that synergize with GCs and quite strongly with each other. This synergy was observed broadly across a large panel of MM and diffuse large B-cell lymphoma (DLBCL) cell lines. Exposure of these cells to A2A agonists and specific PDE inhibitors results in rapid synergistic inhibition of proliferation and induction of apoptosis.

“These findings demonstrate the power of the CombinatoRx combination high-throughput screening (cHTS) technology to rapidly and systematically screen through thousands of single agents and combinations to discover novel and unexpected synergy with potential utility in a variety of proliferative diseases such as multiple myeloma and other B-Cell malignancies,” said Mark H.N. Corrigan, MD, President and CEO of CombinatoRx. “CombinatoRx is continuing to leverage the power of its proprietary platform through research collaborations with biopharmaceutical companies such as our ongoing oncology research collaboration with Novartis.”

...

-------------

Report this comment
#74) On April 14, 2010 at 9:31 AM, portefeuille (99.51) wrote:

sold 22000 CRXX 1.55 USD.

 

Report this comment
#75) On April 14, 2010 at 9:49 AM, portefeuille (99.51) wrote:

sell 870 ATPG, limit 22.50 USD.

Report this comment
#76) On April 14, 2010 at 9:55 AM, portefeuille (99.51) wrote:

sell 4000 MAIL, limit 6.62 USD.

 

update.

performance: +11.24%
cash: -113019.74.

Report this comment
#77) On April 14, 2010 at 11:01 AM, portefeuille (99.51) wrote:

sold 4000 MAIL 6.65 USD.

-------------

IncrediMail Board Approves $4.1 Million Final 2009 Dividend and Announces Record and Payment Dates

Press Release Source: IncrediMail Ltd. On Wednesday April 14, 2010, 8:00 am EDT

TEL AVIV, Israel--(BUSINESS WIRE)--IncrediMail Ltd. (NASDAQ: MAIL - News), an Internet company, today announced that its Board of Directors approved a final cash dividend for 2009 of $0.43 a share, totaling approximately $4.1 million. This dividend is in addition to the interim dividend of $0.40 per share already distributed December 30, 2009, bringing the total dividend for 2009 to $0.83 per share.

...

-------------

Report this comment
#78) On April 14, 2010 at 11:51 AM, portefeuille (99.51) wrote:

sold 350 PALM 5.56 USD (bid).

Report this comment
#79) On April 14, 2010 at 12:37 PM, portefeuille (99.51) wrote:

sold 870 ATPG 22.50 USD.

performance: +11.95%
cash: -64958.74.

yeayyyy!!! hehe ...

Report this comment
#80) On April 14, 2010 at 1:33 PM, portefeuille (99.51) wrote:

sold 35 VECO 48.97 USD (bid).

Report this comment
#81) On April 14, 2010 at 1:49 PM, portefeuille (99.51) wrote:

sold 160 RHT 32.15 USD (bid).

Report this comment
#82) On April 14, 2010 at 1:54 PM, portefeuille (99.51) wrote:

buy 700 ARMH 10.98 USD (ask).

Report this comment
#83) On April 14, 2010 at 2:45 PM, portefeuille (99.51) wrote:

buy 700 ARMH 10.98 USD (ask).

bought 700 ARMH 10.98 USD (ask).

 

sold 900 RSX 36.80 USD (bid).

Report this comment
#84) On April 14, 2010 at 3:23 PM, portefeuille (99.51) wrote:

sold 1100 XNPT 10.22 USD (bid).

Report this comment
#85) On April 14, 2010 at 3:42 PM, portefeuille (99.51) wrote:

buy 1200 OPTR, limit 12.35 USD.

Report this comment
#86) On April 14, 2010 at 4:31 PM, portefeuille2 (99.51) wrote:

bought 1200 OPTR 12.34 USD.

 

performance: +12.48%,
cash: -$36352.79.

performance of some indices for the period starting at the open of 03/08/10 and ending at the close of 04/14/10.

S&P 500 index: +6.35%,
NASDAQ index: +7.68%,
NASDAQ biotech index: +4.24%,
Russell 2000 index: +8.47%.

Report this comment
#87) On April 15, 2010 at 5:41 AM, portefeuille (99.51) wrote:

buy 240 ROG:VX, limit 177.50 CHF.

 

Roche First-Quarter Sales Rise 6% on Oncology Drugs

Report this comment
#88) On April 15, 2010 at 6:09 AM, portefeuille (99.51) wrote:

bought 240 ROG:VX 166.04 USD (175.80 CHF / 1.0588 CHF/USD).

performance: +12.4%.

 

Report this comment
#89) On April 15, 2010 at 8:10 AM, portefeuille (99.51) wrote:

sell 2100 ANDS, limit 3.15 USD, in regular trading or today's pre-market trading.

Report this comment
#90) On April 15, 2010 at 8:15 AM, portefeuille (99.51) wrote:

sold 2100 ANDS 3.20 USD.

72% of Patients Receiving ANA598 in Phase II Combination Study With Interferon and Ribavirin Achieve Undetectable Levels of Virus at Week Eight

Report this comment
#91) On April 15, 2010 at 9:54 AM, portefeuille (99.51) wrote:

buy 3000 ANDS, limit 3.00 USD.

Report this comment
#92) On April 15, 2010 at 10:01 AM, portefeuille (99.51) wrote:

bought 3000 ANDS 3.00 USD.

performance: +12.9%,
cash: -$78561.67.

Report this comment
#93) On April 15, 2010 at 10:04 AM, portefeuille (99.51) wrote:

sell 790 ATPG, limit 23.22 USD.

Report this comment
#94) On April 15, 2010 at 10:17 AM, portefeuille (99.51) wrote:

sold 790 ATPG 23.24 USD.

Report this comment
#95) On April 15, 2010 at 12:25 PM, portefeuille (99.51) wrote:

sell 2100 ARRY, limit 3.13 USD.

Report this comment
#96) On April 15, 2010 at 12:29 PM, portefeuille (99.51) wrote:

sold 300 CML 13.50 USD (bid).

Report this comment
#97) On April 15, 2010 at 12:40 PM, portefeuille (99.51) wrote:

sell 900 DRWI, limit 10.40 USD.
sell 1900 MRNA, limit 1.45 USD.
sell 4000 XOMA, limit 0.92 USD, in regular trading.or today's pre-market trading.
buy to cover 350 HUSA, limit 12.10 USD.

cancel those orders.

Report this comment
#98) On April 15, 2010 at 1:05 PM, portefeuille (99.51) wrote:

sell 1100 ARIA, limit 4.05 USD.

Report this comment
#99) On April 15, 2010 at 2:02 PM, portefeuille (99.51) wrote:

sold 550 XNPT 11.10 USD (bid).

Report this comment
#100) On April 15, 2010 at 2:33 PM, portefeuille (99.51) wrote:

buy 1200 PBTH, limit 4.93 USD.

Report this comment
#101) On April 15, 2010 at 2:51 PM, portefeuille (99.51) wrote:

bought 1200 PBTH 4.92 USD.

bought 140 EWY 52.80 USD (ask).

Report this comment
#102) On April 16, 2010 at 4:00 AM, portefeuille (99.51) wrote:

update.

performance: +12.45%
cash: -63475.07.

Report this comment
#103) On April 16, 2010 at 4:21 AM, portefeuille (99.51) wrote:

the trades.




Report this comment
#104) On April 16, 2010 at 4:30 AM, portefeuille (99.51) wrote:

fund positions.

(1200 shares of ORX:SS are left out as yahoo finance does not do the currency conversion correctly.)



Report this comment
#105) On April 16, 2010 at 6:30 AM, portefeuille (99.51) wrote:

buy 1000 APWR, limit 11.10 USD.

Report this comment
#106) On April 16, 2010 at 6:37 AM, portefeuille (99.51) wrote:

buy 4500 BVB:GR in Xetra or Frankfurt trading, limit 1.195 EUR.

 

#435) On April 18, 2009 at 12:14 PM, portefeuille (99.97) wrote: BVB.DE - 1.17 (0.89 EUR) - outperform

(from here)

Report this comment
#107) On April 16, 2010 at 6:43 AM, portefeuille (99.51) wrote:

bought 4500 BVB:GR 1.608 USD (1.188 EUR * 1.3535 USD/EUR).

Report this comment
#108) On April 16, 2010 at 7:33 AM, portefeuille2 (99.51) wrote:

buy 600 PLND, limit 27.40 USD.

 



enlarge

(from here)

 

http://www.vaneck.com/funds/PLND.aspx

PLND Fact Sheet 4Q09 (pdf)

Report this comment
#109) On April 16, 2010 at 10:04 AM, portefeuille (99.51) wrote:

sold 2100 ARRY 3.13 USD,
bought 1000 APWR 10.69 USD,
bought 600 PLND 26.82 USD.

performance: +12.2%

Report this comment
#110) On April 16, 2010 at 10:57 AM, portefeuille (99.51) wrote:

buy 50 GS, limit 162.50 USD.

Report this comment
#111) On April 16, 2010 at 11:04 AM, portefeuille (99.51) wrote:

buy 50 GS, limit 162.50 USD.

bought 45 GS, 167.30 USD (ask).

Report this comment
#112) On April 16, 2010 at 11:07 AM, portefeuille (99.51) wrote:

sold 420 IMGN 9.89 USD (bid).

Report this comment
#113) On April 16, 2010 at 11:46 AM, portefeuille (99.51) wrote:

bought 7000 AESZ 1.24 USD (ask).

Report this comment
#114) On April 16, 2010 at 11:49 AM, portefeuille (99.51) wrote:

AESZ

AEZS

Report this comment
#115) On April 16, 2010 at 11:53 AM, portefeuille (99.51) wrote:

sell 2600 MAIL, limit 7.08 USD.

Report this comment
#116) On April 16, 2010 at 12:34 PM, portefeuille (99.51) wrote:

#115 order was "partially fillied".

sold 500 MAIL 7.08 USD. cancel the rest of the order.

Report this comment
#117) On April 16, 2010 at 1:29 PM, portefeuille (99.51) wrote:

sell 1500 PBTH, limit 5.25 USD.

Report this comment
#118) On April 16, 2010 at 1:58 PM, portefeuille (99.51) wrote:

buy 2300 MIPI, limit 2.32 USD.

Report this comment
#119) On April 16, 2010 at 2:04 PM, portefeuille (99.51) wrote:

sold 1500 PBTH 5.25 USD,
bought 2300 MIPI 2.32 USD.

Report this comment
#120) On April 16, 2010 at 4:56 PM, portefeuille (99.51) wrote:

update.

performance: +11.11%,

performance of some indices/funds for the period starting at the open of 03/08/10 (the "fund" was started on that day) and ending at the close of 04/16/10.

S&P 500 index: +4.72%,
NASDAQ index: +6.66%,
Russell 2000 index: +7.31%,
iShares MSCI Emerging Markets (EEM): +3.46%,
Vanguard FTSE All-World ex-US (VEU): +3.23%,
NASDAQ biotech index: +3.74%.

Report this comment
#121) On April 17, 2010 at 4:52 AM, portefeuille (99.51) wrote:

continued here.

Report this comment

Featured Broker Partners


Advertisement